Natasha Sheybani, PhD, serves as Senior Scientist at the Focused Ultrasound Foundation, where her role involves supporting research programs in glioblastoma, gene therapy and cancer immunotherapy. She is also an Assistant Professor in Biomedical Engineering and (by Courtesy) Radiology & Medical Imaging at the University of Virginia. She was a Eugene P. Trani Scholar at Virginia Commonwealth University, where she received her B.S. (with Honors) in Biomedical Engineering, as well as an NSF Graduate Research Fellow and Robert R. Wagner Fellow at the University of Virginia, where she earned her PhD in Biomedical Engineering. As a graduate student, Dr. Sheybani became the University of Virginia’s first recipient of The NCI Predoctoral-to-Postdoctoral Fellow Transition Award (F99/K00), which also supported her postdoctoral fellowship in Oncology, Biomedical Data Science and Radiology at Stanford School of Medicine. Dr. Sheybani’s research centers on the use of focused ultrasound technology for potentiation of cancer immunotherapy in solid tumors of the brain and periphery. With the goal of ushering focused ultrasound into the burgeoning era of precision immuno-oncology, her lab employs innovative translational approaches in liquid biopsy, quantitative imaging, and artificial intelligence to non-invasively inform risk stratification, therapeutic monitoring, and individualized treatment paradigms for patients receiving focused ultrasound in combination with immunotherapy.